XML 43 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
OPERATING ACTIVITIES    
Net income $ 11,511 $ 47,041
Adjustments to reconcile net income to net cash provided by/(used in) operating activities:    
Depreciation 14,211 14,345
Amortization 1,663 1,786
Noncash interest expense    405
Change in long-term liabilities, deferred taxes and other credits 3,873 (67,119)
Write-off of pension liability adjustment due to settlement    8,153
Provision for write-off of property, plant and equipment 44 (477)
(Gain) on disposition of assets (3,763) (57,968)
Excess tax benefit of options exercised (352) (3)
Compensation and benefits paid or payable in Class A Common Stock (698) 837
Changes in operating assets and liabilities, net of business divestitures:    
Accounts receivable (1,723) 3,368
Inventories (2,988) (3,912)
Prepaid expenses and other current assets (3,577) (1,616)
Income taxes prepaid and receivable 152 6,560
Accounts payable 547 6,174
Accrued liabilities (8,983) (1,815)
Income taxes payable (5,318) 1,956
Other, net (438) (383)
Net cash provided by/(used in) operating activities 4,161 (42,668)
INVESTING ACTIVITIES    
Purchases of property, plant and equipment (13,188) (4,309)
Purchased software (93) (30)
Proceeds from sale of assets 6,268   
Proceeds from sale of discontinued operations, net of expenses    112,573
Net cash (used in)/provided by investing activities (7,013) 108,234
FINANCING ACTIVITIES    
Proceeds from borrowings 46,868 9,000
Principal payments on debt (32,183) (57,242)
Proceeds from options exercised 1,964 189
Excess tax benefit of options exercised 352 3
Debt acquisition costs (1,563)   
Dividends paid    (4,069)
Net cash provided by/(used in) financing activities 15,438 (52,119)
Effect of exchange rate changes on cash and cash equivalents (3,471) 8,569
Increase in cash and cash equivalents 9,115 22,016
Cash and cash equivalents at beginning of period 190,718 118,909
Cash and cash equivalents at end of period $ 199,833 $ 140,925